单位：[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China肿瘤科华中科技大学同济医学院附属同济医院[2]Tianjin Med Univ Canc Inst & Hosp, Dept Integrat Oncol, Tianjin, Peoples R China[3]Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China[4]Air Force Med Univ, Tangdu Hosp, Dept Oncol, Xian, Peoples R China[5]Peking Univ Canc Hosp & Inst, Dept Integrat Chinese & Western Med, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China[6]Xinxiang Med Univ, Affiliated Hosp 1, Dept Oncol, Xinxiang, Henan, Peoples R China[7]Nanjing Med Univ, Jiangsu Canc Hosp, Dept Med Oncol, Nanjing, Peoples R China[8]Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Peoples R China[9]Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Peoples R China[10]Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Med Oncol, Hangzhou, Peoples R China
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China
推荐引用方式(GB/T 7714)：
Yu S.,Xie G.,Zhang Q.,et al.Oxycodone/naloxone in moderate-to-severe cancer pain: A phase III study in China[J].ANNALS OF ONCOLOGY.2023,34:S1640-S1641.doi:10.1016/j.annonc.2023.10.542.
APA：
Yu, S.,Xie, G.,Zhang, Q.,Zhang, H.,Li, P....&Pan, H..(2023).Oxycodone/naloxone in moderate-to-severe cancer pain: A phase III study in China.ANNALS OF ONCOLOGY,34,
MLA：
Yu, S.,et al."Oxycodone/naloxone in moderate-to-severe cancer pain: A phase III study in China".ANNALS OF ONCOLOGY 34.(2023):S1640-S1641
医学